Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults

BACKGROUND: Herpes zoster may significantly impact quality of life (QoL) in older adults. The recombinant zoster vaccine (RZV) is efficacious in adults aged ≥50 and older and is associated with increased reactogenicity compared to placebo. We report here on the impact of reactogenicity of the second...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmader, Kenneth E, Levin, Myron J, Chen, Michael, Matthews, Sean, Riley, Megan E, Woo, Wayne, Hervé, Caroline, Grupping, Katrijn, Schuind, Anne E, Oostvogels, Lidia, Curran, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
THE JOURNAL OF GERONTOLOGY: Medical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907492/
https://www.ncbi.nlm.nih.gov/pubmed/32530462
http://dx.doi.org/10.1093/gerona/glaa127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907492/
https://www.ncbi.nlm.nih.gov/pubmed/32530462
http://dx.doi.org/10.1093/gerona/glaa127

Ejemplares similares